Dividends Calendar Earnings Calendar
ZYNE

ZYNE | Zynerba Phamaceuticals Inc

Zynerba Phamaceuticals Inc
Category: Pharmaceutical company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Devon, Pennsylvania, United States

Trade prices

  • Volume:
  • Market Cap: 161.71M
  • Prev closed: 4.73
  • Open: 4.95
  • High: 4.95
  • Low: 4.57
  • 52 week low: 2.55
  • 52 week high: 15.7
  • Dividends:No Dividends

Next ER: November 15, 2021 



Top Stories (ZYNE)

    Company Profile

    Zynerba (NASDAQ: ZYNE) is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for transdermal delivery.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 14, 2022
    November 15, 2021-0.26 / -0.252- / -
    August 11, 2021- / -0.2229- / -
    May 12, 2021-0.2 / -0.25- / -
    March 15, 2021- / -0.3286- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jan 18, 2022 2.470 2.520
    2.600
    2.470
    229.18K -6.08%
    Jan 14, 2022 2.630 2.530
    2.670
    2.490
    926.68K 3.14%
    Jan 13, 2022 2.550 2.630
    2.640
    2.510
    777.87K -3.04%
    Jan 12, 2022 2.630 2.730
    2.780
    2.615
    1.26M -3.31%
    Jan 11, 2022 2.720 2.700
    2.780
    2.660
    337.10K 0.74%
    Jan 10, 2022 2.700 2.650
    2.700
    2.580
    548.56K 0.37%
    Jan 7, 2022 2.690 2.720
    2.840
    2.680
    551.84K -0.37%
    Jan 6, 2022 2.700 2.670
    2.760
    2.630
    599.30K 0.75%
    Jan 5, 2022 2.680 2.900
    2.945
    2.675
    1.12M -9.15%
    Jan 4, 2022 2.950 3.060
    3.060
    2.890
    509.83K -2.32%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2007
    • Employees:28

    News

    News for (ZYNE)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Armando Anido
    • General Counsel :  Suzanne M. Hanlon
    • Chief Medical Officer :  Joseph M. Palumbo (Md, Fapa, Macpsych)

    Talk about Zynerba Phamaceuticals Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 15, 2021 (Same day)

    pam zyne qfin optn sndx rmed uavs api athx mark ayro bkyi 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 83
    HOLD 17
    SELL 0

    Their Official Profiles 

    TwitterLinkedIn

    Peers / Similar stocks 

    xlv 

    Other stocks 

    s kmx lrcx bks etr sptn schw agn vips xray veev roku 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.